(R)-Zevaquenabant
(R)-Zevaquenabant R)-MRI-1867) is the enantiomer of Zevaquenabant (HY-141411A). Zevaquenabant S)-MRI-1867) is a peripherally restricted, orally bioavailable dual cannabinoid CB1 receptor and inducible NOS antagonist. Zevaquenabant ameliorates obesity-induced chronic kidney disease (CKD).